CUGBP1 and MBNL1 preferentially bind to 3' UTRs and facilitate mRNA decay

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Masuda, Akio ^a   Andersen, Henriette Skovgaard ^b   Doktor, Thomas Koed ^b   Okamoto, Takaaki ^a   Ito, Mikako ^a   Andresen, Brage Storstein ^b   Ohno, Kinji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CELF1 PROTEIN, HUMAN; MBNL1 PROTEIN, HUMAN; PRIMER DNA; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; CELL LINE; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

3' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; BASE SEQUENCE; CELL LINE; DNA PRIMERS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA-BINDING PROTEINS;

EID: 84859768482     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00209     Document Type: Article

References (54)

1. Licatalosi, D. D. & Darnell, R. B. RNAprocessing and its regulation: global insights into biological networks. Nat Rev Genet 11, 75-87 (2010).
2. Wang, G. S. & Cooper, T. A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8, 749-61 (2007). (Pubitemid 47429207)
3. Brook, J. D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 39 end of a transcript encoding a protein kinase family member. Cell 68, 799-808 (1992).
4. Day, J. W. & Ranum, L. P. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 15, 5-16 (2005). (Pubitemid 41556627)
5. Larkin, K. & Fardaei, M. Myotonic dystrophy-a multigene disorder. Brain Res Bull 56, 389-95 (2001).
6. Lee, J. E. & Cooper, T. A. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 37, 1281-6 (2009).
7. Turner, C. & Hilton-Jones, D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 81, 358-67 (2010).
8. Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 19, 4439-48 (2000).
9. Lin, X. et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15, 2087-97 (2006). (Pubitemid 43923398)
10. Kuyumcu-Martinez, N. M., Wang, G. S. & Cooper, T. A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 28, 68-78 (2007). (Pubitemid 47531966)
11. Iwahashi, C. K. et al. Protein composition of the intranuclear inclusions of FXTAS. Brain 129, 256-71 (2006). (Pubitemid 43063776)
12. Kalsotra, A. et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci USA 105, 20333-8 (2008).
13. Bland, C. S. et al. Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Res (2010).
14. Philips, A. V., Timchenko, L. T. & Cooper, T. A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280, 737-41 (1998). (Pubitemid 28243348)
15. Ho, T. H., Bundman, D., Armstrong, D. L. & Cooper, T. A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 14, 1539-47 (2005). (Pubitemid 40823462)
16. Savkur, R. S., Philips, A. V. & Cooper, T. A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29, 40-7 (2001). (Pubitemid 32801806)
17. Charlet, B. N. et al. Loss of the muscle-specific chloride channel in type 1myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10, 45-53 (2002).
18. Begemann, G. et al. muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development 124, 4321-31 (1997). (Pubitemid 27496867)
19. Teplova, M. & Patel, D. J. Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1. Nat Struct Mol Biol 15, 1343-51 (2008).
20. Ho, T. H. et al. Muscleblind proteins regulate alternative splicing. EMBO J 23, 3103-12 (2004). (Pubitemid 39093604)
21. Cass, D. et al. The four Zn fingers of MBNL1 provide a flexible platform for recognition of its RNA binding elements. BMC Mol Biol 12, 20 (2011).
22. Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy. Science 302, 1978-80 (2003). (Pubitemid 37523508)
23. Fugier, C. et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nature Medicine 17, 720-5 (2011).
24. Moraes, K. C., Wilusz, C. J. & Wilusz, J. CUG-BP binds to RNA substrates and recruits PARN deadenylase. Rna 12, 1084-91 (2006). (Pubitemid 43788126)
25. Vlasova, I. A. et al. Conserved GU-rich elements mediatemRNAdecay by binding to CUG-binding protein 1. Mol Cell 29, 263-70 (2008). (Pubitemid 351172819)
26. Lee, J. E., Lee, J. Y., Wilusz, J., Tian, B. & Wilusz, C. J. Systematic analysis of ciselements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS One 5, e11201 (2010).
27. Rattenbacher, B. et al. Analysis of CUGBP1 Targets Identifies GU-Repeat Sequences That Mediate Rapid mRNA Decay. Mol Cell Biol 30, 3970-80 (2010).
28. Timchenko, N. A., Iakova, P., Cai, Z. J., Smith, J. R. & Timchenko, L. T. Molecular basis for impairedmuscle differentiation in myotonic dystrophy. Mol Cell Biol 21, 6927-38 (2001). (Pubitemid 32911253)
29. Timchenko, N. A. et al. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 279, 13129-39 (2004). (Pubitemid 38445891)
30. Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464-9 (2008). (Pubitemid 352759008)
31. Bailey, T. L. & Elkan, C. The value of prior knowledge in discovering motifs with MEME. Proc Int Conf Intell Syst Mol Biol 3, 21-9 (1995).
32. Marquis, J. et al. CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J 400, 291-301 (2006). (Pubitemid 44852042)
33. Du, H. et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17, 187-93 (2010).
34. Goers, E. S., Purcell, J., Voelker, R. B., Gates, D. P. & Berglund, J. A. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res (2010).
35. Kino, Y. et al. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum Mol Genet 13, 495-507 (2004). (Pubitemid 38313209)
36. Xue, Y. et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell 36, 996-1006 (2009).
37. Hamada, H., Meno, C., Watanabe, D. & Saijoh, Y. Establishment of vertebrate leftright asymmetry. Nat Rev Genet 3, 103-13 (2002).
38. Yashiro, K., Shiratori, H. & Hamada, H. Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch. Nature 450, 285-8 (2007). (Pubitemid 350100536)
39. Dong, F. et al. Pitx2 promotes development of splanchnic mesoderm-derived branchiomeric muscle. Development 133, 4891-9 (2006). (Pubitemid 46085055)
40. Shih, H. P., Gross, M. K. & Kioussi, C. Cranial muscle defects of Pitx2 mutants result from specification defects in the first branchial arch. Proceedings of the National Academy of Sciences of the United States of America 104, 5907-12 (2007). (Pubitemid 47175632)
41. Gherzi, R. et al. Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death and Differentiation 17, 975-83 (2010).
42. Chen, H. H., Xu, J., Safarpour, F. & Stewart, A. F. LMO4 mRNA stability is regulated by extracellular ATP in F11 cells. Biochem Biophys Res Commun 357, 56-61 (2007). (Pubitemid 46574499)
43. Zhang, L., Lee, J. E., Wilusz, J. & Wilusz, C. J. The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem 283, 22457-63 (2008).
44. Horb, L. D. & Horb, M. E. BrunoL1 regulates endoderm proliferation through translational enhancement of cyclin A2 mRNA. Dev Biol (2010).
45. Yeo, G. W. et al. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat Struct Mol Biol 16, 130-7 (2009).
46. Llorian, M. et al. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat Struct Mol Biol 17, 1114-23 (2010).
47. Hino, S. et al. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum Mol Genet 16, 2834-43 (2007). (Pubitemid 350048382)
48. Sen, S. et al. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer. J Biol Chem 285, 25426-37 (2010).
49. Ule, J., Jensen, K., Mele, A. & Darnell, R. B. CLIP: amethod for identifying protein-RNA interaction sites in living cells. Methods 37, 376-86 (2005). (Pubitemid 41682508)
50. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-95 (2010).
51. Rhead, B. et al. The UCSC Genome Browser database: update 2010. Nucleic Acids Res 38, D613-9 (2010).
52. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-2 (2010).
53. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57 (2009).
54. Dennis, G., Jr. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3 (2003).